Drug Discovery & Pharmaceuticals

RSS
New chemical reaction enables precise functionalization of peptides and proteins

New chemical reaction enables precise functionalization of peptides and proteins

Microphysiological systems in drug discovery

Microphysiological systems in drug discovery

New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

Insilico Medicine reaches preclinical milestone in MASH drug discovery

Insilico Medicine reaches preclinical milestone in MASH drug discovery

New antibiotic design could end the arms race with resistant bacteria

New antibiotic design could end the arms race with resistant bacteria

Breakthrough method opens door to fluorinated oxetane drug molecules

Breakthrough method opens door to fluorinated oxetane drug molecules

New computational tool iDOMO improves prediction of drug synergy

New computational tool iDOMO improves prediction of drug synergy

AI-driven discovery unveils TNIK inhibition as anti-aging strategy

AI-driven discovery unveils TNIK inhibition as anti-aging strategy

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Zinc-carrying proteins may activate PPIs in the absence of gastric acid

Zinc-carrying proteins may activate PPIs in the absence of gastric acid

Breakthrough computational tool enhances design of targeted antiviral therapies

Breakthrough computational tool enhances design of targeted antiviral therapies

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

Innovative approach to synthesizing functional molecules with triple click chemistry

Innovative approach to synthesizing functional molecules with triple click chemistry

Insilico Medicine develops highly selective FGFR2/3 dual inhibitor for cancer treatment

Insilico Medicine develops highly selective FGFR2/3 dual inhibitor for cancer treatment

Yokogawa releases OpreX Quality Management System to accelerate DX in quality assurance processes for the manufacturing of pharmaceuticals and food & beverages

Yokogawa releases OpreX Quality Management System to accelerate DX in quality assurance processes for the manufacturing of pharmaceuticals and food & beverages

Optibrium widens access to industry-leading docking method

Optibrium widens access to industry-leading docking method

CN Bio launches physioMimix DILI assay kit: Human 24, for enhanced preclinical toxicology testing

CN Bio launches physioMimix DILI assay kit: Human 24, for enhanced preclinical toxicology testing

INTEGRA Biosciences' reagent dispenser now supports SiLA-2 integration

INTEGRA Biosciences' reagent dispenser now supports SiLA-2 integration

Schrödinger selects Sapio Sciences to enhance in silico drug discovery from plasmid to structure

Schrödinger selects Sapio Sciences to enhance in silico drug discovery from plasmid to structure

New approach uses peptides to enhance anti-tumor drug formulations

New approach uses peptides to enhance anti-tumor drug formulations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.